Systemic therapies for psoriatic disease and serious adverse events in older adults: a population-based cohort study

No abstract available.

Information

Citation

Drucker AM, Sutradhar R, Ling V, Eder L, Gomes T, Fralick M, Iskandar RJ, Li P, MacDougall S, Manolson M, Rochon PA, Tadrous M. J Invest Dermatol. 2025; S0022-202X(25)03528-6. Epub 2025 Nov 15.

View Source

Contributing ICES Scientists

Research Programs

Chronic Disease & Pharmacotherapy

Associated Topics

Associated Sites

ICES Central

Discover More

Journal Article

1 octobre 2026

Intravenous thrombolysis for acute ischemic stroke across kidney function

Bota SE, Dixon S, Kapral MK, Hackam D, Sood MM, Sontrop JM, Garg AX. Nephrol Dial Transplant. 2026; Oct 1 [Epub ahead of print].

Journal Article

1 octobre 2026

Trends in population attributable risk of Clostridioides difficile infection associated with common outpatient antibiotics in Ontario, Canada, 2017-2024

Wong MK, Daneman N, Langford BJ, Leung V, Schwartz KL, Brown KA. Infect Control Hosp Epidemiol. 2026; Oct 1 [Epub ahead of print].

Journal Article

1 octobre 2026

Retention in rheumatology care across the juvenile idiopathic arthritis care pathway: from diagnosis through transition

Kwok TSH, Lee JJY, Morais S, Barber CEH, Batthish M, Berard R, Feldman BM, Levy DM, Steiman A, Widdifield J. J Rheumatol. 2026; Oct 1 [Epub ahead of print].

See All